Isaacs syndrome is the most well-known autoimmune peripheral nerve hyperexcitability (PNH) syndrome (Ahmed and Simmons, 2015) . Clinically, patients with Isaacs syndrome are characterized by visible myokymia at rest and by doublet, triplet, or multiplet single unit discharges in needle electromyography (nEMG) (Newsom-Davis and Mills, 1993) . Antibodies against voltage-gated potassium channels (VGKC), which suppress the function of fast potassium channels (K v1 ), have been detected in some patients with the syndrome (approximately 38-50%). In contrast, Shimatani et al. recently reported four cases of cramp fasciculation syndrome/PNH syndrome associated with dysfunction of slow potassium channels (K v7 ), and they proposed the concept of slow potassium channelopathy (Shimatani et al., 2015) . However, the aetiology of slow potassium channelopathy, such as causative antibodies or gene mutations, remains unknown. Here, we report two cases of Isaacs syndrome associated with slow potassium channelopathy and describe their serological background.
Case 1 was a 46-year-old female diagnosed with myasthenia gravis and recurrent thymoma who underwent extended thymectomy and six courses of chemotherapy that included cisplatin and vincristine. Six months after the chemotherapy, she developed myokymia, fasciculations, and muscle cramps in both lower limbs (Supplementary Video). Physiological examination showed hyperhidrosis. Neurological examinations revealed the absence of grip myotonia, ptosis, diplopia, dysarthria, dysphasia, and muscular weakness. Electrophysiological evaluations were performed. A nerve conduction study (NCS) showed a mild decrease in the amplitude of sensory nerve action potentials (SNAPs) and marked afterdischarges in an F-wave examination (Fig. 1A) . In a repetitive nerve stimulation test, decrement of compound muscle action potential amplitude was not observed. Needle EMG showed fasciculation potentials and myokymic discharges (marked multiplets; Fig. 1B) .
Case 2 was an 81-year-old woman who underwent a total resection for colon cancer and subsequent oral chemotherapy at 72 years of age. At the age of 77, she noticed gradual paraesthesia and pain in both hands and feet. At the age of 80, she developed myokymia and muscle cramps in both legs. Neurological examinations revealed myokymia, fasciculations, and stiffness in the thigh muscles; paraesthesia and sensory loss were present in both hands and lower limbs. Autonomic symptoms, hyperhidrosis, grip myotonia, ptosis, diplopia, dysarthria, dysphasia, and muscle weakness were absent. Decreased SNAP amplitude and repetitive afterdischarges in F-wave examination were demonstrated in NCS, and frequent fasciculation potentials and myokymic discharges were detected by nEMG.
Based on clinical symptoms and the results of electrophysiological tests, both patients were diagnosed with Isaacs syndrome.
To investigate the pathophysiological background of marked myokymia, we conducted a nerve excitability study using commercially available software (QTRACS with TRONDNF excitability protocol) and examined the functional parameters of the median nerve axon (Supplementary methods).
In the nerve excitability tests, both patients showed a lack of accommodation to depolarizing threshold electrotonus (Fig. 1C ) and late subnormality in the recovery cycle (Fig. 1D) , both of which suggest an impaired axonal slow potassium current (Shimatani et al., 2015) . The strength-duration time constants in the patients (0.38 ms in Case 1 and 0.23 ms in Case 2) were lower than the mean of the control group (0.40 ms ± 0.01 SE). These findings are consistent with those reported by Shimatani et al. Therefore, we hypothesized that a similar impairment of slow potassium channel function is the underlying pathogenesis in both patients. Subsequently, we performed mathematical modelling of the excitability data to confirm the impaired slow potassium current, but it was unsuccessful.
To clarify the serological background of the disease, we screened autoantibodies including anti-VGKC antibodies. Furthermore, because the patients had a history of malignancy, we performed a paraneoplastic autoantibody analysis (Supplementary methods). In Case 1, the titres of anti-AChR, anti-TPO, and anti-thyroglobulin were elevated. In Case 2, the titre of anti-cardiolipin antibody was increased (Supplementary Table S1 ). Anti-VGKC antibodies were absent in both cases. Paraneoplastic autoantibody analysis showed the presence of anti-CRMP5 (IgG) antibody only in Case 1.
We identified two patients with anti-VGKC antibody-negative Isaacs syndrome with evidence of slow potassium channel dysfunction revealed by nerve excitability tests. Both our cases showed (1) Isaacs syndrome with visible myokymia in the lower limbs without grip myotonia, (2) negative findings for anti-VGKC antibodies, (3) marked myokymic discharges (multiplet) on nEMG, (4) marked afterdischarges on an F-wave test, and (5) evidence of decreased slow potassium current in nerve excitability tests. These clinical and electrophysiological characteristics were also present in four cases reported by Shimatani et al., which suggests that they could be clinical and electrophysiological hallmarks of anti-VGKCantibody-negative Isaacs syndrome associated with slow potassium channel dysfunction. Our findings also indicate the critical role of decreased axonal slow potassium current in the genesis of visible myokymia and electrophysiological myokymic discharges.
Serological tests revealed anti-CRMP5 antibodies in Case 1 and anti-cardiolipin antibodies in Case 2. Anti-CRMP5 antibodies are associated with paraneoplastic neurological syndrome, and its diverse clinical symptoms include peripheral neuropathy, but neuromyotonia has rarely been reported (Vernino and Lennon, 2002 
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